Abstract:Lung cancer is the leading cause of cancer mortality worldwide with 40% of cases diagnosed as lung adenocarcinoma (LADC). Increased expression of RET has been reported in 10-20% of LADCs and is associated with metastasis and reduced survival. Alternative gene splicing of RET generates two co-expressed isoforms; RET9 and RET51, with unique C-terminal tails. The tails confer distinct protein binding opportunities with signaling proteins, known as scaffolds, to promote different signaling events and cell processes. RET9 interacts with the SHANK family scaffolds at a PDZ-binding motif and Enigma at tyrosine (Y) 1062, whereas, RET51 interacts with Grb2 at the unique Y1096. RET9 and RET51 are associated with distinct functions in thyroid cancer, where RET51plays a predominant role in cancer metastasis. Ezrin is a scaffold protein and tyrosine kinase substrate that bridges the plasma membrane to the actin cytoskeleton to promote adhesion, organization and migration. Overexpression of ezrin is associated with invasion and metastasis of osteosarcoma and pancreatic cancer cells. The roles of RET isoform-scaffold interactions in the progression of LADC has never been investigated. HEK-293 cells were co-transfected with RET isoform or mutant constructs and Ezrin and/or Grb2 dominant negative (DN) constructs. A549 LADC cells were transfected with RET51 construct. SH-SY5Y neuroblastoma and HCC1833 LADC cells endogenously express Ezrin and RET. Cells were treated with RET/ Ezrin inhibitors and/or stimulated with glial-derived neurotrophic factor (GDNF) then fixed or harvested. Co-immunoprecipitation (Co-IP) or pull-down assays coupled to western blotting were used to investigate binding domains required for RET interaction with and activation of Ezrin or downstream effectors. Immunofluorescence confocal imaging was used to determine co-localization of RET and Ezrin and changes to cell morphology. GDNF-impregnated agarose bead live-cell fluorescence assays were used to measure cell growth, survival, spread and motility. SynTarget (cancer gene expression analysis tool) was used to assess co-expression of RET and Ezrin with respect to clinicopathological parameters and survival outcomes in LADC. Ezrin binds kinase active RET51 with Grb2. GDNF-stimulation promotes the formation of cytoskeletal outgrowths with increased co-localization of Ezrin and RET. GDNF-activation of RET results in scaffold-mediated activation of Rho-family GTPases to promote cell motility. Like RET, overexpression of Ezrin is associated with poor overall survival in LADC patients and overexpression of both RET and Ezrin has a negative synergistic effect on overall survival in a subset of LADC patients. RET interaction with Ezrin identifies a distinct functional role of RET as an oncogenic driver in lung adenocarcinoma.

Interaction of Sh2-B Beta with Ret is Involved in Signaling of Gdnf-Induced Neurite Outgrowth

BRI3 Associates with SCG10 and Attenuates NGF-induced Neurite Outgrowth in PC12 Cells

Protein-tyrosine Phosphatase SHP2 Contributes to GDNF Neurotrophic Activity Through Direct Binding to Phospho-Tyr687 in the RET Receptor Tyrosine Kinase

Smoothened-Independent Activation of Hedgehog Signaling by Rearranged During Transfection Promotes Neuroblastoma Cell Proliferation and Tumor Growth

Rap1GAP Interacts with RET and Suppresses GDNF-induced Neurite Outgrowth

Ret is a Multifunctional Coreceptor That Integrates Diffusible- and Contact-Axon Guidance Signals.

Ret-Independent Signaling By Gdnf Ligands And Gfr Alpha Receptors

Study on Interaction Between Suc1-Binding Neurotrophic Target 1 and RET by Yeast Two-Hybrid Method

RET Signaling in Prostate Cancer

Retrolinkin cooperates with endophilin A1 to mediate BDNF-TrkB early endocytic trafficking and signaling from early endosomes.

Identification of a Key Motif That Determines the Differential Surface Levels of RET and TrkB Tyrosine Kinase Receptors and Controls Depolarization Enhanced RET Surface Insertion

ShcD Interacts with TrkB Via Its PTB and SH2 Domains and Regulates BDNF-induced MAPK Activation.

Phosphoproteome Study Reveals Hsp27 As a Novel Signaling Molecule Involved in GDNF-induced Neurite Outgrowth.

Ureteric bud outgrowth in response to RET activation is mediated by phosphatidylinositol 3-kinase

Deletion of Shp2 in the brain leads to defective proliferation and differentiation in neural stem cells and early postnatal lethality.

Identification of the Key Amino Acids of Glial Cell Line-derived Neurotrophic Factor Family Receptor Α1 Involved in Its Biological Function

Nigrostriatal Projecting Neurons Express GDNF Receptor Subunit RET in Adult Rats

GDNF-induced Cell Signaling and Neurite Outgrowths Are Differentially Mediated by GFRalpha1 Isoforms.

The Association of GSK3β with E2F1 Facilitates Nerve Growth Factor-induced Neural Cell Differentiation

Cloning and Characterization of Glial Cell Line-Derived Neurotrophic Factor Receptor-B: A Novel Receptor for Members of Glial Cell Line-Derived Neurotrophic Factor Family of Neurotrophic Factors

P2.03-19 RET-Mediated Activation of Ezrin is Associated with Cell Motility and Survival in a Subset of Lung Adenocarcinomas